0001415889-24-002809.txt : 20240206
0001415889-24-002809.hdr.sgml : 20240206
20240206164203
ACCESSION NUMBER: 0001415889-24-002809
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240202
FILED AS OF DATE: 20240206
DATE AS OF CHANGE: 20240206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alam Kamran
CENTRAL INDEX KEY: 0001793412
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39536
FILM NUMBER: 24600858
MAIL ADDRESS:
STREET 1: 350 FIFTH AVENUE, SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc.
CENTRAL INDEX KEY: 0001806310
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 843199512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 PEGASUS PARK DRIVE
STREET 2: SUITE 1430
CITY: DALLAS
STATE: TX
ZIP: 75247
BUSINESS PHONE: (214) 612-0000
MAIL ADDRESS:
STREET 1: 3000 PEGASUS PARK DRIVE
STREET 2: SUITE 1430
CITY: DALLAS
STATE: TX
ZIP: 75247
4
1
form4-02062024_090255.xml
X0508
4
2024-02-02
0001806310
Taysha Gene Therapies, Inc.
TSHA
0001793412
Alam Kamran
C/O TAYSHA GENE THERAPIES, INC.
3000 PEGASUS PARK DRIVE, STE 1430
DALLAS
TX
75247
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Common Stock
2024-02-02
4
F
0
1288
1.51
D
840937
D
Represents shares withheld by the Issuer to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary transaction by the Reporting Person.
/s/ Kamran Alam
2024-02-06